Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 58,876 | 30,064 | 23,443 | 9,335 | 1,740 |
| Gross Profit | 58,876 | 30,064 | 23,443 | 9,335 | 1,740 |
| Operating Expenses | 103,126 | 88,211 | 73,302 | 38,084 | 45,314 |
| Operating Income | -44,250 | -58,147 | -49,859 | -28,749 | -43,574 |
| Interest Expense | 98 | 476 | 816 | 775 | 338 |
| Other Income | 12,267 | 3,191 | 255 | 1,578 | 2,060 |
| Pre-tax Income | -32,081 | -55,432 | -50,420 | -27,946 | -41,852 |
| Income Tax | 103 | 2,330 | -87 | -6 | N/A |
| Net Income Continuous | -32,184 | -57,762 | -50,333 | -27,940 | -41,852 |
| Net Income | $-32,184 | $-57,762 | $-50,333 | $-27,940 | $-41,852 |
| EPS Basic Total Ops | -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
| EPS Basic Continuous Ops | -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
| EPS Diluted Total Ops | -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
| EPS Diluted Continuous Ops | -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
| EBITDA(a) | $-51,725 | $-58,250 | $-48,333 | $-28,068 | $-43,466 |